It’s no secret that pharmaceutical companies aggressively market their products to doctors in hopes of driving prescriptions, and a new investigation in STAT shows just how intertwined marketing and medicine are. Reporter Olivia Goldhill details how a marketer working for Pfizer helped develop a depression screening tool that is still widely—and, in many cases, improperly—used today. |